RenovoRx Investor Relations Material
Latest events
Q1 2025
RenovoRx
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from RenovoRx Inc
Access all reports
RenovoRx Inc is a U.S.-based medical technology company focused on targeted drug delivery systems. It develops catheter-based platforms for the localized administration of chemotherapy and other therapeutics, primarily for treating cancers. The company aims to improve patient outcomes by reducing systemic exposure and enhancing precision in treatment delivery. It is headquartered in Los Altos, California, and its shares are listed on the NASDAQ.
Key slides for RenovoRx Inc
Investor Presentation
RenovoRx Inc
Investor Presentation
RenovoRx Inc
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
RNXT
Country
🇺🇸 United States